Background: Preclinical evidence suggests that general anesthetics can dose dependently induce neurodegeneration in the developing brains of animals which can be reliably determined by measurement of blood S100b, but this correlation remains unclear in humans. We hypothesized that S100b would not be increased in cord arterial blood of fetuses exposed briefly to general anesthetics during a C-section, compared with epidural anesthesia. Methods: A prospective observational clinical study comparatively measured changes of brain damage biomarker S100b ratio of umbilical artery over vein (changes after fetus circulation) immediately after delivery under C-section with either epidural or general anesthesia. Newborn blood gas measurements, APGAR scores, and maternal well-being were also compared. Results: Compared with epidural anesthesia, general anesthesia resulted in the lower S100b ratio of umbilical artery over the vein (medium 2.64 [quartiles 1.39, 3.45] vs. medium 1.59 [quartiles 0.88, 2.01], P = 0.031), without changing the S100b level in the vein of the mother. There was no significant difference between general and epidural anesthesia when comparing other maternal and newborn parameters. Conclusion: S100b levels in newborn after C-section is lower with general anesthesia than epidural anesthesia, with unclear mechanisms.
Background: Preclinical evidence suggests that general anesthetics can dose dependently induce neurodegeneration in the developing brains of animals which can be reliably determined by measurement of blood S100b, but this correlation remains unclear in humans. We hypothesized that S100b would not be increased in cord arterial blood of fetuses exposed briefly to general anesthetics during a C-section, compared with epidural anesthesia. Methods: A prospective observational clinical study comparatively measured changes of brain damage biomarker S100b ratio of umbilical artery over vein (changes after fetus circulation) immediately after delivery under C-section with either epidural or general anesthesia. Newborn blood gas measurements, APGAR scores, and maternal well-being were also compared. Results: Compared with epidural anesthesia, general anesthesia resulted in the lower S100b ratio of umbilical artery over the vein (medium 2.64 [quartiles 1.39, 3 .45] vs. medium 1.59 [quartiles 0.88, 2.01], P = 0.031), without changing the S100b level in the vein of the mother. There was no significant difference between general and epidural anesthesia when comparing other maternal and newborn parameters. Conclusion: S100b levels in newborn after C-section is lower with general anesthesia than epidural anesthesia, with unclear mechanisms.
Editorial comment
In this observational, uncontrolled trial, S100b was measured in newborns delivered by C-section. The level of S100b was compared between those with mothers receiving general anesthesia and those with mothers receiving epidural anesthesia. The S100b levels were lower in newborns delivered with general anesthesia, but the mechanism and the consequences of this are unclear.
Preclinical data from both tissue cultures and animal studies suggest a neuroprotective effect of general anesthetics (GAs) against various stresses including hypoxia and ischemia. 1, 2 However, GAs have also been shown to be especially neurotoxic to the developing brain of various animal species in a dose-and timedependent manner and may be associated with long-term learning or developmental disorders. [3] [4] [5] Unfortunately, neither the neuroprotective nor the neurotoxic effects of GAs have been clearly confirmed in human subjects. The mechanisms of general anesthesia-mediated dual effects of both neuroprotection and neurotoxicity in preclinical studies are unclear, although several hypotheses have been proposed.
It is, therefore, essential that the dual effects of neuroprotection and neurotoxicity by GAs in the developing brain are clearly defined and confirmed in human studies. The high sensitivity of the developing brain to the neurotoxic properties of GAs as described in preclinical studies 6, 7 is concerning to parents whose children receive general anesthesia for various surgeries. However, there is controversial retrospective clinical data on whether GAs used in the developing brain cause long-term learning disability or developmental disorders, with some supporting [8] [9] [10] and refuting evidence in the literature. 11, 12 Two recent international multicenter prospective clinical trials detected no general anesthesia-associated neurodevelopmental or neurobehavioral disorders, 13, 14 although the possible long-term neurotoxic effects of GAs at high concentration for prolonged use could not be excluded.
Both prospective and retrospective clinical trials have examined the long-term learning and behavioral disability, resulting from anesthetic exposure to the developing brain using a battery of complex behavioral tests. Availability of a reliable biomarker to detect anesthesia neurotoxicity acutely in the developing brain can advance the research in this area positively. A commonly used biomarker for brain damage is a calcium-binding protein primarily from glial cells, S100b, which has been considered a sensitive biomarker to detect brain damage after various stresses, including ischemia 15 and trauma. 16, 17 S100b is a sensitive and reliable biomarker to predict fetus hypoxia and ischemia damage in pregnant patients and has been used for such purposes. 15 Our previous studies have also demonstrated the use of plasma S100b as a sensitive biomarker to detect brain damage when the fetus brain is exposed to a high concentration of general anesthetics, with a good correlation between the level of apoptosis and the exposure to general anesthesia detected in the fetus brain.
18 S100b has been shown to be valuable in animal models for detecting general anesthesia-mediated acute neurologic damage in the developing brain. [18] [19] [20] However, its effectiveness and usefulness to reflect anesthesia-associated brain damage in human subjects are yet to be confirmed.
Although most cesarean sections (C-sections) are completed under epidural anesthesia, emergent and elective cesarean deliveries occasionally need to be completed under general anesthesia. In such instances, the fetus brain may be briefly exposed to GAs during the Csection. It is not clear whether a brief exposure of the developing fetal brain to general anesthesia is harmful. Umbilical artery blood come from the fetus circulation and reflects changes on fetus side, while the umbilical vein blood originate from the placenta and demonstrate changes on mother side. Utilizing the brain damage biomarker, S100b, we compared the ratio of S100b from umbilical artery over vein (UA/UV) immediately after delivery (after fetus circulation) from newborn delivered with C-section under either epidural or general anesthesia. We hypothesized that the brain damage biomarker, S100b, would not be increased in cord arterial blood of fetuses exposed briefly to general anesthetics during a C-section, compared with epidural anesthesia.
Materials and methods
Two similar clinical study protocols were approved by the institutional review board (IRB) from the Shanghai First Maternity and Infant Hospital (SFMIH), Tongji University School of Medicine, Shanghai, China, and the Hospital of the University of Pennsylvania (HUP), Philadelphia, USA, separately. The study protocol was registered in the Chinese Clinical Trial Registry (registration no. ChiCTR-OOC-15007163). Written informed consent was obtained from patients scheduled for C-section under epidural or general anesthesia. The inclusion criteria included American Society of Anesthesiologists physical status I or II and term gestation at 36 weeks or more. Exclusion criteria included age < 18 years, known maternal neurologic abnormality, known fetal neurologic defect; preeclampsia, diabetes mellitus, intrauterine growth retardation, or allergy to any study medication.
The indications for general anesthesia (GA) in this patient population were as follows: obstetrician request based on maternal and fetus status for emergent C-section. Elective C-section were elected secondary to maternal request after failed regional block, coagulopathy/bleeding risk, history of lumbar traumatic injuries or operation, severe lumbar disc protrusion and rachioscoliosis, history of bad back pain and/or laminectomy, back infection, scare of needle on back. All C-sections under GA in SFMIH were elective while all cases at HUP were emergent. A total of 160 patients were screened and 77 recruited at SFMIH, while 86 patients were screened and 24 recruited at HUP for the study between February 2012 and May 2015.
Anesthesia
During the C-section, patients were maintained in the supine position with a 15-degree left lateral tilt. Electrocardiogram measurements, noninvasive blood pressure (NBP) readings of the left upper arm, and pulse oxygen saturation (SpO 2 ) were obtained. A baseline NBP reading including systolic, diastolic, and mean blood pressures (SAP, DAP, MAP) were measured and documented.
Patients in the epidural anesthesia (EA) group were placed in the right lateral or sitting position. EA was administered at the L2-L3 vertebral interspace through an epidural catheter, which was secured at 3-5 cm into the epidural space. The parturient was, thereafter, returned to the supine position with a 15°left lateral tilt. EA induction and maintenance was achieved with 1.5% lidocaine, sodium bicarbonate, and 1 : 200,000 epinephrine. Oxygen at 4 l/min was administered via nasal catheter. Surgery was initiated when the sensory block level was above T6 and Bromage score was ≥ grade 3.
Patients in the GA group were induced with propofol 2 mg/kg and succinylcholine 2 mg/kg intravenously and maintained with 0.75 MAC of sevoflurane at SFMIH or 0.75 MAC of desflurane at HUP. Surgery was initiated after verification of the appropriate placement and position of the endotracheal tube by capnography. An observer collected all intraoperative data. Occurrence of hypotension and hypoxia were recorded. Hypotension was defined as a greater than 20% decrease in SAP below the baseline value and was treated with intravenous phenylephrine. Hypoxia was defined as SpO 2 < 95%. Time from anesthesia induction to incision and time from incision to delivery were also noted.
After the delivery of the baby, the neonatal condition was evaluated by the pediatricians and Apgar scores (at 1 and 5 min) were assigned and documented. Immediately after delivery of baby from the uterus, a portion of umbilical cord (~10-15 cm) was clamped on both side to prevent loss of blood and the newborn baby was then separated from the placenta by cutting the cord between the clamp away from the placenta side and the newborn baby. The placenta was delivery shortly after baby delivery, and 1-5 ml of blood was taken from the umbilical vein and artery between two clamped sides immediately after placenta delivery. This protocol will assure that cord arterial blood S100b between two clamps was not contaminated by the placenta S100b after the clamping and reflected true S100b concentrations in cord arterial blood originated from the newborn. A portion of the blood was immediately injected into a blood gas/electrolyte analyzing system (ABL-80 FLEX, Radiometer) for blood partial pressure of CO 2 (PCO 2 ), blood partial pressure of O 2 (PO 2 ), blood pH, and base excess (BE), and the remaining blood sample was used for the S100b study assay. Five milliliters of blood was also taken from the mother via the existing peripheral intravenous catheter for S100b assay. The blood samples were immediately centrifuged at 349 g for 10 min and the supernatant collected and stored at minus 80-degree temperature until the measurement of S100b level.
S100b serum concentrations were measured using ELISA assay. Commercially available ELISA kits were used: EZHS100B-33K, Human S100b ELISA, EMD Millipore, Billerica, MA, USA, was used at SFMIH, and Sangtec â 100
ELISA, DiaSorin Inc., Stillwater, MN, USA, was used at HUP. Following the manufacturer's protocol, each sample was incubated with the tracer from the kit for 2 h. Then, tetramethylbenzidine was added. The reaction was then stopped with stop solution and the absorbance of the samples read at 450 and 590 nm using Spectramax M5 plate reader (Molecular Devices, Sunnyvale, CA, USA) at SFMIH, and read at 450 nm by Synergy H1 microplate reader (Bio-Tek Instruments Inc., Winooski, VT, USA) at HUP. The standard concentration curve was plotted to determine the concentrations of the samples. We had a deviation from original study protocol. The concentration of S100b in maternal amniotic fluid was not reported, for it is extremely low and could not be measured by S100b kit.
Statistical analyses
The primary outcome was the group differences of S-100b level in umbilical blood in the GA group and EA group. The secondary outcomes were group differences in umbilical blood gas measurements and neonatal outcomes.
Based on previous study, 21 a sample size of 32 per group calculated by power analysis PASS 11 (NCSS, Kaysville, UT) was required to achieve a statistical power of 91%, at a 5% level of significance. Univariate intergroup data were tested for normality using the KolmogorovSmirnov test. Demographic data and blood gas parameters were presented as means, if normally distributed, or as median and range, if not normally distributed, and group differences were compared using Student's t-test or the Mann-Whitney U-test when appropriate. Nominal data were compared using the chi-square test or Fisher's exact test. Analyses were performed using GraphPad Prism Software (Version 6.1) for Windows. Two-sided P values < 0.05 were considered statistically significant.
Results
Patient recruitment and flow are presented in Fig. 1 . Seventy-seven patients at SFMIH and 24 patients at HUP were recruited for the study, but after exclusions, data were analyzed from 63 patients at SFMIH and 23 patients at HUP. Twenty-seven patients received general anesthesia and 36 patients received epidural anesthesia at SFMIH. Three patients received general anesthesia and 20 patients received epidural anesthesia at HUP. Although initial design intended to combine data from two hospitals as a two centers clinical trial, the pattern of inclusion and the practical details of the assay prevented this possibility. The difficulty includes the variation in patient population and the different measurement kits for S100b by the different staff and the unbalanced patient population for general anesthesia for elective or emergent C-section. Therefore, we have presented the data from the two different hospitals separately. Nonetheless, parallel comparisons between the two hospitals, especially for the trend of changes, are analyzed and discussed.
Demographics and clinical characteristics of patients at SFMIH are shown in Table 1 . Patients in both groups were similar in age, weight, height, body mass index, parity, gestational age, and incidence of hypotension or hypoxia after anesthesia induction. Time from anesthesia induction to incision in the EA group was longer than the GA group (25 AE 3.4 vs. 4.1 AE 0.8 min, P < 0.001), and time from incision to delivery (min) was also significantly longer in the EA group compared with the GA group (5.9 AE 1.8 vs. 5.0 AE 1.1 min, P = 0.039).
Neonatal outcome at SFMIH was also summarized in Table 2 . All Apgar scores at 1 and 5 min were similar. The mean neonatal weight and gender were not significantly different between the EA and GA groups. Blood gas readings of the umbilical artery (UA) and umbilical vein (UV) in the SFMIH patients only are presented in Table 2 . There were no differences in the pH, PCO 2 , PO 2 and base excess (BE) between both groups at SFMIH. Fetal blood gas measurements were unavailable at HUP.
Demographics and clinical characteristics (maternal and neonatal) of the patients at HUP are presented in Table 3 . Patients in the EA group were older than those in the GA group (P = 0.046). Apgar scores (1 and 5 min) of neonates in GA group were significantly lower than those in the EA group. Time from anesthesia induction to incision in the EA group was significantly longer when compared with the GA group (21.0 AE 5.2 vs. 3.3 AE 2.6 min, P = 0.001). There were no significant differences in weight, height, body mass index, parity, gestational age, and incidence of hypotension or hypoxia between two groups. Data presented as mean AE SD or n (%). Group differences were compared using Student's t-test. Nominal data were compared using the chi-square test. SFMIH, Shanghai First Maternity and Infant Hospital in China; EA, epidural anesthesia; GA, general anesthesia.
As shown in Fig. 2 , although there were no significant differences in the UA or UV S100b concentration between the EA and GA groups in both hospitals ( Fig. 2A and B) , the S100b UA/UV ratio was significantly lower with GA than EA (Fig. 2C) in SFMIH. Interestingly, the changes in the trend of S100b UA/UV ratio at HUP (Fig. 2D) were similar to the results seen at SFMIH although statistical difference was not achieved most likely due to the sample size, which was underpowered. Although no statistical difference (P = 0.061), UA and UV difference (UA-UV) in GA group (0.059 [À0.012, 0.165] lg/l) clearly trended to be lower than that in EA group (0.198 [0.038, 0.394] lg/l) in SFMIH (Fig. 2E) . The absolute UA and UV difference (UA-UV) in HUP was also presented in Fig. 2F , with same trend as in SFMIH. There was no significant difference in the maternal venous S100b of the patients at SFMIH (Fig. 3) .
These results demonstrated a significant decrease of UA/UV S100b ratio after general anesthesia compared to epidural anesthesia, but no significant changes of S100b in maternal mother vein, suggesting that the short exposure of general anesthetics to the fetus developing brain does not increase neurodegeneration biomarkers acutely.
Discussion
It is generally accepted that properly designed prospective controlled clinical trials provide more valuable information for clinical practice than retrospective clinical studies. Given the multiple controversial results from available retrospective studies about anesthetic neurotoxicity in the developing human brain, it is essential that more prospective clinical trials be performed for definitive or better conclusions on this subject matter. Primary outcomes of two currently ongoing international randomized controlled clinical studies (GAS and PANDA studies) are focused on studying learning and developmental disorders by the use of a battery of behavioral tests. 13, 14, 22 The use of biomarkers as a reliable diagnostic tool for identifying acute damage by general anesthetics in the developing brain would be desirable. Some animal studies suggested a good correlation between elevated plasma S100b and pathological neurodegeneration in the developing brain. [18] [19] [20] 23 In addition to its high sensitivity to detect fetal brain damage from asphyxia or stresses before birth, 15, [24] [25] [26] S100b is clearly a good candidate to be tested in related clinical studies. This study suggests that S100b can be used to detect general anesthesia-mediated neurodegeneration in the developing brain because the trend of S100b changes of UA, UV, and UA/UV from two different hospitals are the same, suggesting it is a reliable peripheral biomarker from different patient populations. In addition, these results are also consistent with previous retrospective clinical studies indicating that multiple exposures rather than a single exposure to GAs during infancy contribute to increased learning disability. 8 A previous study has demonstrated that children born via C-section under general anesthesia did not have increased long-term developmental disorders when compared with those born under epidural anesthesia. 12 The range of S100b in umbilical cord blood during normal delivery without anesthesia varied widely in different studies, for examples, 0.32 lg/l (range 0.18-5.27 lg/l), 29 In this study, the median level of S100b level in UA and UV under general vs. epidural anesthesia was 0.230 lg/l vs. 0.310 lg/l and 0.133 lg/l vs. 0.113 lg/l, respectively, higher S100b in UA with epidural anesthesia than general anesthesia. The UA/UV ratio will reflect the percentage change after fetus blood circulation, presumably after CNS circulation also. One explanation of general anesthesia mediated lower lever of S100b is that short exposure of general anesthetics may cause mild to moderate elevation of cytosolic calcium concentration via activation of InsP3 or ryanodine receptors, inducing endogenous neuroprotective mechanisms 30 and reduce the release of S100b into blood stream. More clinical trials in the future are needed to confirm the sensitivity and specificity of S100b to detect possible anesthesia-mediated harmful effects to the developing brain when used at extreme high concentrations, such as during fetal surgery. 31, 32 It is not clear why UA/UV S100b ratio is significantly lower in newborns delivered with C-section under GA than EA. One possible explanation is that the short exposure to GA may provide neuroprotection against stresses during delivery by preconditioning. 1, 23, 33 If the dual effects of neuroprotection and neurotoxicity of GAs are based on the concentration and duration of anesthesia as proposed in the preclinical studies, 30, 34 it is speculative that extreme high concentration and prolonged duration of GA used during fetal surgery 31, 32 may have an increased risk of anesthesiarelated neurotoxicity in the fetal developing brain. Another possible reason could be due to the duration from start of induction of anesthesia to the delivery of the newborn, which is much faster under GA than EA, hence decreasing the exposure of the developing brain to various stress factors that could subsequently increase S100b. Nevertheless, the results from this study at least suggest that short exposure of general anesthetics to fetus developing brains during C-section was less likely to cause fetal brain damage, although the mechanisms why GAs decreased S100b, compared to EA, is not clear.
It is interesting to note that the S100b level in the maternal vein was not significantly different between GA and EA, contrary to the significant decrease with the newborn UA/UV S100b ratio after general anesthesia. Considering the fact that the adult brain is much less vulnerable to anesthesia neurotoxicity than the developing brain 7, 35, 36 in conjunction with the short exposure of GA to the maternal CNS during C-section, it is possible that the differences in the changes of S100b between the fetus and mother reflect the high vulnerability of the developing brain to anesthesia neurotoxicity demonstrated in preclinical studies. 5, 7 However, the level of plasma S100b in the mother's vein may be affected by multiple factors, such as contribution from the fat or muscle due to the incision of the abdominal wall and the uterus. In other words, the S100b level in the mother's vein may not be as specific as its indication of brain neurodegeneration as in the fetus UA/UV ratio. A previous study had demonstrated that EA during C-section may significantly suppress the level of stresses in both mother and fetus, 37 which may also contribute to the decreased level of S100b compared to the GA during C-section in this study.
Although the clinical protocols utilized in both institutions [University of Pennsylvania Hospital (HUP) and the Shanghai First Maternity and Infant Hospital (SFMIH)] were the same, the kits used to measure S100b were not from the same company. This may contribute to the different baseline level of S100b and, thus, made it difficult to combine the data from the two hospitals. However, the trend changes of S100b in UA, UV, and the UA/UV ratio were similar in both hospitals, a strength supporting the reliability of utilizing S100b as a brain damage biomarker in this clinical protocol. It is obvious that the number of GAs at HUP were too low to perform any meaningful statistical analysis. This is mostly due to the considerably decreased probability of using GA for elective C-sections in the United States and the significant time restraint involved in obtaining study consent before an emergent C-section. The percentage of patients who received EA for labor analgesia at SFMIH (40-60%) is obviously lower than HUP (> 90%), hence increasing the likelihood of receiving GA for urgent C-section much higher at HUP. Nevertheless, the parallel comparison of S100b data from two hospitals and the similar changes in trend observed strengthen the reliability of S100b as a brain damage biomarker in this patient population. Due to the lack of desflurane at SFMIH, a different volatile anesthetic (sevoflurane) was used, however, at equivalent concentration (0.75 MAC). This may have had a confounding effect if data from the two different hospitals were combined for statistical analysis. Although S100b is a highly sensitive biomarker to detect brain damages by various harmful factors, 17 it is relatively less specific as there are S100b. Extraneural sources of S100b also include muscle, kidney, and heart. 38, 39 So the specificity of S100b for acute brain injury is generally low. 40 A combination of different biomarkers, such as neuron-specific enolase (NSE), glial fibrillary acidic protein (GFAP), and tau protein, will be needed to improve predictive ability of brain injury in further work. S100b in blood is regarded as extracellular S100B passing into the blood through a disrupted blood-brain barrier (BBB). 41 Hence, increased blood concentrations of S100B is considered an early marker of the disruption of BBB after head injury, thus not always as a sign of neuronal damage. Measures are necessary to minimize S100b contribution from other source other than CNS. The relatively high Apgar score of newborn baby from elective C-section at SFMIH vs. low APGAR scores in newborn from emergent C-section at HUP under general anesthesia warrants future studies with more emergent cases for adequate power to perform proper statistical analysis.
Because this is not a randomized controlled study, it is difficult to eliminate some confounding factors that cause fetal stress and changes in S100b. Nevertheless, we have tried our best to compare the most commonly seen cofounders that may cause fetal stress during or after C-section, such as maternal hypoxia or hypotension, fetal blood gas, and Apgar score. There was no significant difference between general vs. epidural anesthesia on these monitored parameters.
In summary, general anesthesia during Csection did not increase but decreased biomarker S100b in newborn blood compared with epidural anesthesia, implicating a decreased likelihood for GA-mediated fetus brain damage during C-section. 
